Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8 — Abdul Qader Sukkurwala (2013) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8
Shared by
Guido Guido Kroemer
Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8
Article
2013
en
Authors
+15 more
AS
Abdul Qader Sukkurwala
IM
Isabelle Martins
YW
Y Wang
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2010
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Laurence Zitvogel
,
Oliver Kepp
,
Laura Senovilla
,
Laurie Menger
,
Nathalie Chaput
,
Guido Guido Kroemer
Article
2007
Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference
Nathalie Chaput
,
Stéphane de Botton
,
Michel Obéid
,
Lionel Apétoh
,
François Ghiringhelli
,
Theocharis Panaretakis
,
Caroline Flament
,
Laurence Zitvogel
,
Guido Guido Kroemer
Article
2009
Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals
Frank Madeo
,
Michael Durchschlag
,
Oliver Kepp
,
Theocharis Panaretakis
,
Laurence Zitvogel
,
Kai-Uwe Fröhlich
,
Guido Guido Kroemer
Article
2009
Adenine nucleotide translocase: a component of the phylogenetically conserved cell death machinery
Boris Zhivotovsky
,
Lorenzo Galluzzi
,
Oliver Kepp
,
Guido Guido Kroemer
Article
2019
Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death
Lenka Kašíková
,
Iva Truxová
,
Isabelle Cremer
,
Catherine Sautès‐Fridman
,
Oliver Kepp
,
Guido Guido Kroemer
,
Radek Špíšek
,
Jitka Fučíková
Discussion(0)
No comments yet. Be the first to comment.